Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Policy of screening for colorectal cancer in Saudi Arabia: A prospective analysis.

Aljumah AA, Aljebreen AM.

Saudi J Gastroenterol. 2017 May-Jun;23(3):161-168. doi: 10.4103/sjg.SJG_468_16.

2.

Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests.

Green BB, BlueSpruce J, Tuzzio L, Vernon SW, Aubree Shay L, Catz SL.

BMC Public Health. 2017 May 30;17(1):531. doi: 10.1186/s12889-017-4458-6.

3.

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.

Goede SL, Rabeneck L, van Ballegooijen M, Zauber AG, Paszat LF, Hoch JS, Yong JH, Kroep S, Tinmouth J, Lansdorp-Vogelaar I.

PLoS One. 2017 Mar 15;12(3):e0172864. doi: 10.1371/journal.pone.0172864. eCollection 2017.

4.

Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.

Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):903-909.e6. doi: 10.1016/j.cgh.2016.08.037. Epub 2016 Sep 5.

PMID:
27609707
5.

Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH).

Green BB, Anderson ML, Chubak J, Baldwin LM, Tuzzio L, Catz S, Cole A, Vernon SW.

J Am Board Fam Med. 2016 Mar-Apr;29(2):191-200. doi: 10.3122/jabfm.2016.02.150290.

6.

Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.

Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW.

Cancer. 2016 Jan 15;122(2):312-21. doi: 10.1002/cncr.29734. Epub 2015 Oct 21.

7.

The impact of preventive screening resource distribution on geographic and population-based disparities in colorectal cancer in Mississippi.

Faruque FS, Zhang X, Nichols EN, Bradley DL, Reeves-Darby R, Reeves-Darby V, Duhé RJ.

BMC Res Notes. 2015 Sep 8;8:423. doi: 10.1186/s13104-015-1352-0.

8.

Molecular markers for colorectal cancer screening.

Dickinson BT, Kisiel J, Ahlquist DA, Grady WM.

Gut. 2015 Sep;64(9):1485-94. doi: 10.1136/gutjnl-2014-308075. Epub 2015 May 20. Review.

9.

Importance of reporting segmental bowel preparation scores during colonoscopy in clinical practice.

Jain D, Momeni M, Krishnaiah M, Anand S, Singhal S.

World J Gastroenterol. 2015 Apr 7;21(13):3994-9. doi: 10.3748/wjg.v21.i13.3994.

10.

Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.

Jeon J, Meza R, Hazelton WD, Renehan AG, Luebeck EG.

Cancer Causes Control. 2015 Jun;26(6):859-70. doi: 10.1007/s10552-015-0559-7. Epub 2015 Mar 18.

11.

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018.

Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, Jemal A, Lansdorp-Vogelaar I.

Cancer. 2015 Jul 1;121(13):2281-5. doi: 10.1002/cncr.29336. Epub 2015 Mar 12.

12.

The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?

Zauber AG.

Dig Dis Sci. 2015 Mar;60(3):681-91. doi: 10.1007/s10620-015-3600-5. Epub 2015 Mar 5. Review.

13.

Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study.

Coronado GD, Burdick T, Petrik A, Kapka T, Retecki S, Green B.

J Gen Pract (Los Angel). 2014 Jan 5;2. pii: 1000141.

14.

Optimising the expansion of the National Bowel Cancer Screening Program.

Cenin DR, St John DJ, Ledger MJ, Slevin T, Lansdorp-Vogelaar I.

Med J Aust. 2014 Oct 20;201(8):456-61.

15.
16.

Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.

Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB.

Contemp Clin Trials. 2014 Jul;38(2):344-9. doi: 10.1016/j.cct.2014.06.006. Epub 2014 Jun 14.

17.

Age and cancer risk: a potentially modifiable relationship.

White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ.

Am J Prev Med. 2014 Mar;46(3 Suppl 1):S7-15. doi: 10.1016/j.amepre.2013.10.029.

18.

Systems intervention to promote colon cancer screening in safety net settings: protocol for a community-based participatory randomized controlled trial.

James AS, Richardson V, Wang JS, Proctor EK, Colditz GA.

Implement Sci. 2013 Jun 3;8:58. doi: 10.1186/1748-5908-8-58.

19.

An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.

Green BB, Wang CY, Anderson ML, Chubak J, Meenan RT, Vernon SW, Fuller S.

Ann Intern Med. 2013 Mar 5;158(5 Pt 1):301-11. doi: 10.7326/0003-4819-158-5-201303050-00002.

20.

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.

Chang Y, Schechter CB, van Ravesteyn NT, Near AM, Heijnsdijk EA, Adams-Campbell L, Levy D, de Koning HJ, Mandelblatt JS.

Breast Cancer Res Treat. 2012 Dec;136(3):823-35. doi: 10.1007/s10549-012-2274-3. Epub 2012 Oct 27.

Supplemental Content

Support Center